Over 400 thought leaders from 200+ organizations, representing 21 countries, gathered at the Biomarker World Congress 2009 (May 27-29 in Philadelphia) to discuss the biomarker impact on Personalized Medicine, Clinical Pharmacology, Translational Medicine, Molecular Diagnostics, Safety Assessment, Clinical Trials, Assay Development, Go/No-Go Decision Making and Oncology in Drug & Diagnostics. The level of energy and participation reflected the booming interest in this field.

Comprehensive Coverage of Biomarkers in:
Personalized Medicine
Clinical Pharmacology
Translational Medicine
Molecular Diagnostics
Safety Assessment
Clinical Trials
Assay Development
Biomarker Qualification
Oncology Drugs & Diagnostics